Always ensure you check the product details or consult with your doctor to confirm suitability
In combination with neuropsychiatric drugs, GLP-1RAs did not increase the risk of developing SSIBs
2016 Jan;157:84-104
Jimenez-Solem E, Rasmussen MH, Christensen M, Knop FK (2010) Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes
The CFS sample (N = 12) included to following co-occurring diagnoses (N = 6) made at least 1 year before starting L-carnitine supplementation in the study: asthma (N =1), allergic rhinitis (N = 1), celiac sprue (N = 1), type 1 diabetes (N = 1), prostate hypertrophy (N = 1), and gastro-esophageal reflux disease (N = 1)
Its broad applicability and life-changing impact have made it the standard of care in many regions